EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Establishment of a Novel IDH1 wild type Glioblastoma Cell Line, SHG142, and Its Organoids

Heyang Gao, Hao Wang, Lin Yao, Guozheng Zhao, Liyan Tang, Xiao Zhang, Jialiang Qian, Xiyang Weng, Youxin Zhou

Frontiers in Bioscience-Landmark · 2026-03-26 · 31 (4)

DOI: 10.31083/fbl49045 ↗

At a glance

Journal article in Frontiers in Bioscience-Landmark, published online on 2026-03-26. Written by Heyang Gao and 8 co-authors. Institution: Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 215000 Suzhou, Jiangsu, China. Major MEDLINE topics: Glioblastoma, Isocitrate Dehydrogenase, Organoids, Brain Neoplasms. 35 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Glioblastoma (GBM) is the most aggressive primary malignant brain tumor and is associated with limited treatment options and poor prognosis. Conventional GBM cell lines undergo genetic drift and progressive divergence from patient-relevant molecular features over long-term culture, limiting their translational relevance. This study aimed to establish and characterize a novel isocitrate dehydrogenase 1 (IDH1)-wildtype GBM cell line, SHG142, along with its associated glioma stem-like cells (GSCs) and organoid models, to advance GBM biology and therapeutic research.

Methods

Primary tumor tissue from a 70-year-old female patient was cultured under standard conditions to generate the SHG142 cell line, which was authenticated by short tandem repeat (STR) profiling. Phenotypic and genetic features were evaluated using immunofluorescence (IF), karyotyping, and whole-exome sequencing (WES) including a concordance analysis between an early bulk primary culture (P2) and late-passage SHG142 (P50). GSCs were isolated via serum-free culture and magnetic-activated cell sorting (MACS). Tumorigenicity and invasiveness were assessed through intracranial xenografts in nude mice (n = 6/group) and coculture with brain organoids derived from human embryonic stem cells (n = 4 independent organoids).

Results

SHG142 cells exhibited stable morphology and proliferation over more than 50 passages, retained key GBM markers (e.g., Nestin, Glial Fibrillary Acidic Protein (GFAP), O6-methylguanine-DNA methyltransferase (MGMT), Ki-67, P53, S-100, CD34), and exhibited chromosomal instability (+7, –10, and t(9;13)). WES revealed mutations in the TERT promoter, TP53 and NF1 and supported lineage continuity from P2 to P50 through shared SNVs and conserved driver events. CD133+ SHG142 GSCs demonstrated stem-like properties and invasive behavior in vivo and in organoid coculture. Compared with xenografts derived from SHG142 cells, GSC-derived xenografts were associated with increased malignancy and shorter survival (median survival 25 vs. 31.5 days, p = 0.025). The organoid coculture model confirmed deep infiltration by proliferative, stem-like tumor cells.

Conclusions

SHG142 and its GSCs represent a phenotypically stable, genetically defined GBM model with evidence of lineage continuity and retention of key driver events during in vitro propagation. Their tumorigenic and invasive properties make them valuable tools for mechanistic studies and preclinical therapeutic screening, supported by initial two-dimensional and three-dimensional drug response readouts that enable first-pass evaluation of therapeutic response.

Subjects

MeSH terms (MEDLINE)

GlioblastomaIsocitrate DehydrogenaseOrganoidsBrain NeoplasmsHumansFemaleAnimalsMiceAgedCell Line, TumorMice, NudeNeoplastic Stem Cells

Author keywords

cell line, tumorexome sequencingglioblastomaneoplastic stem cellsorganoids

Substances

Isocitrate DehydrogenaseIDH1 protein, human

Authors and institutions

  • Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 215000 Suzhou, Jiangsu, China.

Funding

  • National Natural Science Foundation of China

Cite

APA

Gao, H., Wang, H., Yao, L., Zhao, G., Tang, L., Zhang, X., Qian, J., Weng, X., & Zhou, Y. (2026). Establishment of a Novel IDH1 wild type Glioblastoma Cell Line, SHG142, and Its Organoids. Frontiers in Bioscience-Landmark, 31(4). https://doi.org/10.31083/fbl49045

Vancouver

Gao H, Wang H, Yao L, Zhao G, Tang L, Zhang X, et al. Establishment of a Novel IDH1 wild type Glioblastoma Cell Line, SHG142, and Its Organoids. Frontiers in Bioscience-Landmark. 2026;31(4). doi:10.31083/fbl49045

BibTeX
@article{Gao2026,
  author = {Gao, Heyang and Wang, Hao and Yao, Lin and Zhao, Guozheng and Tang, Liyan and Zhang, Xiao and Qian, Jialiang and Weng, Xiyang and Zhou, Youxin},
  title = {Establishment of a Novel IDH1 wild type Glioblastoma Cell Line, SHG142, and Its Organoids},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  volume = {31},
  number = {4},
  doi = {10.31083/fbl49045}
}
Start for free →